MIRAMAR, Fla., Feb. 12, 2026 /PRNewswire/ -- DifGen Pharmaceuticals, a leading US based generic pharmaceutical company, today announced that it has received approval from the U.S. Food and Drug ...
AHMEDABAD, India, May 08, 2025--(BUSINESS WIRE)--Zydus Lifesciences Limited (including its subsidiaries/ affiliates, hereafter referred to as "Zydus") has received final approval from the United ...
OneSource Specialty Pharma says partner Orbicular secures USFDA tentative approval for generic Ozempic semaglutide injection, ...
Mumbai, November 5, 2008: Sun Pharmaceutical Industries Ltd. (Reuters:SUN.BO, Bloomberg:SUNP IN, NSE:SUNPHARMA, BSE:524715) announced that USFDA has granted approval for the Abbreviated New Drug ...
The move is part of a broader push to onshore pharmaceutical production and reduce reliance on foreign suppliers, particularly from India and China. The US Food and Drug Administration (FDA) has ...
Cipla receives USFDA approval for its generic albuterol sulfate inhalation aerosol, enhancing its respiratory treatment ...
MUMBAI, India--(BUSINESS WIRE)--Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE:SUNPHARMA, BSE: 524715) announced that USFDA has granted its subsidiary an approval for its ...
Alembic Pharmaceuticals Limited ( (IN:APLLTD) ) has issued an update.
Granules India on Thursday, January 8, 2026, announced that its wholly owned US subsidiary, Granules Pharmaceuticals Inc. (GPI), has received tentative approval from the U.S. Food and Drug ...
Granules India gets USFDA nod for ADHD drug with 180-day exclusivity. The US market size for the ADHD drug is estimated at $41 million. Granules aims to build a differentiated portfolio of complex ...
Company Gets 180 Day Marketing Exclusivity on a First-to-file ANDA With Para IV Certification MUMBAI, India, October 10, 2007-Sun Pharmaceutical Industries Ltd. announced that USFDA has granted final ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results